Lataa...
Risk and management of patients with mastocytosis and MCAS in the SARS-CoV-2 (COVID-19) pandemic: Expert opinions
The coronavirus disease 2019 (COVID-19) (caused by severe acute respiratory syndrome coronavirus 2) pandemic has massively distorted our health care systems and caused catastrophic consequences in our affected communities. The number of victims continues to increase, and patients at risk can only be...
Tallennettuna:
| Julkaisussa: | J Allergy Clin Immunol |
|---|---|
| Päätekijät: | , , , , , , , , , , , , , , , , , , , , , , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
The Authors. Published by Elsevier Inc. on behalf of the American Academy of Allergy, Asthma & Immunology.
2020
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7297685/ https://ncbi.nlm.nih.gov/pubmed/32561389 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jaci.2020.06.009 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|